|
|
Article: Monsanto and TwistDx Begin Field Trials of Rapid Diagnostic Tests for More Efficient Delivery of Biotech Crops.
- Article from:
- Biotech Week
- Article date:
- August 19, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
TwistDx, a developer of point-of-use nucleic acid diagnostics, announced that they have made strong progress toward developing rapid, DNA-based field tests with Monsanto Company (NYSE:MON). Monsanto plans to use the tests to enhance the efficiency with which biotechnology crops are delivered across the globe (see also TwistDx).
To develop the tests, the companies are using TwistDx's proprietary Recombinase Polymerase Amplification (RPA) technology. RPA is a novel DNA amplification technology that enables the tests to produce results faster than other DNA detection tests available today, while maintaining a very high level of specificity and sensitivity.
...